anti-Synaptic Vesicle Glycoprotein 2A (SV2A) Antikörper

membrane glycoprotein\; acts as a synaptic vesicle-specific transporter [RGD, Feb 2006].. Zusätzlich bieten wir Ihnen SV2A Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
SV2A 64051 Q9JIS5
SV2A 117559 Q02563
SV2A 9900 Q7L0J3
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-SV2A Antikörper auf antikoerper-online.de

Showing 10 out of 44 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
358,51 €
Details
Ratte Ziege Unkonjugiert ELISA, WB ABIN185715 (0.3µg/ml) staining of rat brain lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 100 μg Anmelden zum Anzeigen 3 bis 4 Tage
349,82 €
Details
Human Kaninchen Unkonjugiert ICC, IF, IHC, IHC (p), IP, WB Western Blot: SV2A Antibody  - Analysis in human cell line U-87 MG. Immunohistochemistry-Paraffin: SV2A Antibody  - staining of human cerebral cortex shows distinct positivity in neuropil. 0.1 mL Anmelden zum Anzeigen 5 bis 8 Tage
335,00 €
Details
Hund Ziege Unkonjugiert WB   0.1 mg Anmelden zum Anzeigen 8 bis 11 Tage
357,50 €
Details
Ratte Ziege Unkonjugiert ELISA, WB ABIN188574 (0.3?g/ml) staining of Rat Brain lysate (35?g protein in RIPA buffer).  Primary incubation was 1 hour.  Detected by chemiluminescence. Western Blot: SV2A Antibody [ABIN1885742] - (0.3ug/ml) staining of rat brain lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 0.1 mg Anmelden zum Anzeigen 2 bis 4 Tage
311,00 €
Details
Fledermaus Ziege Unkonjugiert ELISA, WB 100 μg Anmelden zum Anzeigen 11 bis 14 Tage
722,86 €
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB Formalin-fixed and paraffin embedded rat brain labeled with Anti-SV2A Polyclonal Antibody, Unconjugated  at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL Anmelden zum Anzeigen 9 bis 12 Tage
304,36 €
Details
Human Kaninchen Unkonjugiert ELISA, WB 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
459,65 €
Details
Human Kaninchen Unkonjugiert WB SV2A antibody used at 0.5 ug/ml to detect target protein. 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
460,89 €
Details
Ratte Ziege Unkonjugiert ELISA, WB 0.1 mg Anmelden zum Anzeigen 6 bis 8 Tage
505,48 €
Details

SV2A Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Mouse (Murine) , ,
, , ,
,
, , , , , , , , , , , , ,
Rat (Rattus) , ,
, , ,
,
, , , , , , , , , , , , , , , ,
Human , , ,
, , ,
,
, , , , , , , , , , , , ,

Am meisten referenzierte anti-SV2A Antikörper

  1. Human Polyclonal SV2A Primary Antibody für ICC, IF - ABIN4357125 : Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. in Nature methods 2013 (PubMed)
    Show all 2 Pubmed References

  2. Rat (Rattus) Polyclonal SV2A Primary Antibody für ELISA, WB - ABIN188574 : Dong, Yeh, Tepp, Dean, Johnson, Janz, Chapman: SV2 is the protein receptor for botulinum neurotoxin A. in Science (New York, N.Y.) 2006 (PubMed)

Weitere Antikörper gegen SV2A Interaktionspartner

Mouse (Murine) Synaptic Vesicle Glycoprotein 2A (SV2A) Interaktionspartner

  1. This study reveals fundamental details of how phosphorylation of Thr84 on SV2A controls its interaction with synaptotagmin-1 (zeige SYT1 Antikörper) and implicates SV2A as a phospho-dependent chaperone

  2. observed alterations of SV2A expression in hippocampus are consistent with the hypothesis that SV2A absence favors epileptic seizures around postnatal day 7

  3. Action potential- and Ca(2 (zeige CA2 Antikörper)+) -dependent glutamatergic & GABAergic synaptic transmission are differentially altered in the hippocampus of SV2A-deficient mice, but the mechanism of exocytosis itself is not changed.

  4. Glycosylation is dispensable for sorting of synaptotagmin 1 (zeige SYT1 Antikörper) but is critical for targeting of SV2 and synaptophysin (zeige SYP Antikörper) to recycling synaptic vesicles.

  5. study suggests that SV2A specifically regulates hilar GABAergic neurotransmission in the kindled hippocampus probably as a compensatory or prophylactic mechanism against kindling epileptogenesis

  6. Loss of synaptic vesicle glycoprotein 2a is associated with inhibition of tetanus neurotoxin into central neurons.

  7. These results indicate that SV2 performs at least two actions at the synapse that contribute to neurotransmitter release.

  8. SV2A is selectively localized in motor nerve terminals on slow (type I and small type IIA) muscle fibers.

  9. SV2 action modulates synaptic networks by ensuring that low-frequency neurotransmission is faithfully conveyed.

  10. findings show that botulinum neurotoxin (BoNT/A) enters neurons by binding to the synaptic vesicle protein SV2 (isoforms A, B, and C);SV2 acts as the protein receptor for BoNT/A

Human Synaptic Vesicle Glycoprotein 2A (SV2A) Interaktionspartner

  1. Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines.

  2. SV2A expression in the bladder urothelium increases after BoNT-A injection.

  3. the way LEV analogues may interact with SV2A

  4. agents that act on the conformation of SV2A might hold great potential in the search for new SV2A-based anticonvulsant therapies

  5. The newly identified galactose transport capability of SV2A may have an important role in regulating/modulating synaptic function.

  6. The SV2A/FE65 (zeige APBB1 Antikörper) interaction might play a role in synaptic signal transduction.

  7. In classical mesial temporal sclerosis 1A, the expression of SV2 isoforms is altered with a marked decrease of SV2A paralleling synaptic loss.

  8. High SV2A expression is associated with breast cancer.

  9. This study in the German population provides evidence, at a genetic level, for the involvement of the SV2A gene region in schizophrenia.

  10. Data report a combined modelling and mutagenesis study that successfully identifies another 11 residues in synaptic vesicle protein 2A that appear to be involved in ligand binding.

SV2A Antigen-Profil

Protein Überblick

membrane glycoprotein\; acts as a synaptic vesicle-specific transporter

Genbezeichner und Symbole assoziert mit SV2A

  • synaptic vesicle glycoprotein 2A (SV2A) Antikörper
  • synaptic vesicle glycoprotein 2A (CpipJ_CPIJ017596) Antikörper
  • synaptic vesicle glycoprotein 2A (sv2a) Antikörper
  • synaptic vesicle glycoprotein 2 a (Sv2a) Antikörper
  • synaptic vesicle glycoprotein 2a (Sv2a) Antikörper
  • AI746429 Antikörper
  • mKIAA0736 Antikörper
  • SV2 Antikörper

Bezeichner auf Proteinebene für SV2A

synaptic vesicle glycoprotein 2 , synaptic vesicle glycoprotein 2A , synaptic vesicle glycoprotein 2A-like , calcium regulator SV2A , synaptic vesicle protein 2 , synaptic vesicle protein 2A , synaptic vesicle transmembrane transporter (SV2) RNA , p87

GENE ID SPEZIES
457264 Pan troglodytes
6051544 Culex quinquefasciatus
100379721 Xenopus (Silurana) tropicalis
100396256 Callithrix jacchus
100465293 Ailuropoda melanoleuca
100597057 Nomascus leucogenys
100618145 Monodelphis domestica
64051 Mus musculus
117559 Rattus norvegicus
9900 Homo sapiens
101748163 Gallus gallus
280936 Bos taurus
483176 Canis lupus familiaris
100156610 Sus scrofa
100173959 Pongo abelii
Ausgewählte Anbieter für anti-SV2A (SV2A) Antikörper
Haben Sie etwas anderes gesucht?